. . . . . . . "10.1002/HEP.510270429" . "27" . "wetenschappelijk artikel"@nl . . . . . "Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group"@nl . . "Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group"@nl . . . . . . . . . . . . . . . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u n'abril de 1998"@ast . "1121-1127" . "R D Goldin" . . . . "1998-04-01T00:00:00Z"^^ . . . . . . "Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group"@nl . . "4" . . "Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study"@en . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0443 \u043A\u0432\u0456\u0442\u043D\u0456 1998"@uk . "im April 1998 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . "B R Bacon" . . "Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group"@en . "9537453" . . . "Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group"@en . . . . . . "G C Farrell" . . "scientific article published on 01 April 1998"@en . . . . . . . . . . . . . . . . "Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group"@en . . . . . . . . . . . . . . . . . . . . . . .